Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
Tertiapin LQ is a peptide derivative of the honeybee venom peptide tertiapin and an inhibitor of... more
Product information "Tertiapin LQ (trifluoroacetate salt)"
Tertiapin LQ is a peptide derivative of the honeybee venom peptide tertiapin and an inhibitor of inwardly rectifying potassium (Kir) channels. It inhibits heteromultimeric potassium channels composed of G protein-activated inward rectifier potassium channel 1 (GIRK1) and GIRK4, also known as Kir3.1 and Kir3.4, respectively, as well as the inward-rectifier potassium channel 1 (Kir1.1). In vivo, tertiapin LQ suppresses the Purkinje cell pause response to a conditional stimulus in ferrets. Formal Name: 2,2'-((2S,5S,8R,11S,14S,17S,20R,25R,28S,31S,34S,37S,40S,42aS,49S,52R)-11-((1H-indol-3-yl)methyl)-20-((2-(((S)-6-amino-1-(((S)-1,6-diamino-1-oxohexan-2-yl)amino)-1-oxohexan-2-yl)amino)-2-oxoethyl)carbamoyl)-5-(3-amino-3-oxopropyl)-14,17-bis(4-aminobutyl)-52-((S)-2-((S)-2-aminopropanamido)-4-methylpentanamido)-34,37,40-tri((S)-sec-butyl)-31-(3-guanidinopropyl)-2-isobutyl-3,6,9,12,15,18,26,29,32,35,38,41,42,48,51-pentadecaoxodotetracontahydro-1H,24H-25,8-(epiminoethanoiminopropanodithiomethano)pyrrolo[1,2-x][1,2]dithia[5,8,11,14,17,20,23,24,29,32,35,38,41]tridecaazacyclotetratetracontine-28,49-diyl)diacetamide, trifluoroacetate salt. Synonyms: TPNLQ. Molecular Formula: C106H179N33O24S4 . XCF3COOH. Formula Weight: 2428.0. Purity: >98%. Formulation: (Request formulation change), A solid. Peptide Sequence: ALCNCNRIIIPLQCWKKCGKK-NH2. Solubility: Water: Soluble. SMILES: [H]N[C@H](C(N[C@@H](CC(C)C)C(N[C@H](C(N[C@@H](CC(N)=O)C(N[C@H](C(N[C@@H](CC(N)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@]([C@H](CC)C)([H])C(N[C@]([C@H](CC)C)([H])C(N[C@]([C@H](CC)C)([H])C(N1CCC[C@H]1C(N[C@@H](CC(C)C)C(N[C@@H](CCC(N)=O)C2=O)=O)=O)=O)=O)=O)=O)=O)=O)CSSC[C@H](N3)C(NCC(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N)=O)=O)=O)=O)=O)=O)CSSC[C@H](N2)C(N[C@H](C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C3=O)=O)=O)CC4=CNC5=C4C=CC=C5)=O)=O)=O)C.OC(C(F)(F)F)=O. InChi Code: InChI=1S/C106H179N33O24S4.C2HF3O2/c1-12-56(8)83-103(161)137-84(57(9)13-2)104(162)138-85(58(10)14-3)105(163)139-42-26-34-78(139)102(160)131-70(44-55(6)7)94(152)126-68(35-36-79(112)140)92(150)133-75-51-166-167-52-76(134-95(153)69(43-54(4)5)127-87(145)59(11)111)100(158)130-73(47-81(114)142)98(156)135-77(101(159)129-72(46-80(113)141)97(155)125-67(93(151)136-83)33-25-41-118-106(116)117)53-165-164-50-74(88(146)120-49-82(143)121-64(30-18-22-38-108)89(147)122-63(86(115)144)29-17-21-37-107)132-91(149)66(32-20-24-40-110)123-90(148)65(31-19-23-39-109)124-96(154)71(128-99(75)157)45-60-48-119-62-28-16-15-27-61(60)62,3-2(4,5)1(6)7/h15-16,27-28,48,54-59,63-78,83-85,119H,12-14,17-26,29-47,49-53,107-111H2,1-11H3,(H2,112,140)(H2,113,141)(H2,114,142)(H2,115,144)(H,120,146)(H,121,143)(H,122,147)(H,123,148)(H,124,154)(H,125,155)(H,126,152)(H,127,145)(H,128,157)(H,129,159)(H,130,158)(H,131,160)(H,132,149)(H,133,150)(H,134,153)(H,135,156)(H,136,151)(H,137,161)(H,138,162)(H4,116,117,118),(H,6,7)/t56-,57-,58-,59-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,83-,84-,85-,/m0./s1. InChi Key: ZPLMSISGLVMRNO-BOYOOOHJSA-N.
| Keywords: | TPNLQ, 2,2'-((2S,5S,8R,11S,14S,17S,20R,25R,28S,31S,34S,37S,40S,42aS,49S,52R)-11-((1H-indol-3-yl)methyl)-20-((2-(((S)-6-amino-1-(((S)-1,6-diamino-1-oxohexan-2-yl)amino)-1-oxohexan-2-yl)amino)-2-oxoethyl)carbamoyl)-5-(3-amino-3-oxopropyl)-14,17-bis(4-aminob |
| Supplier: | Cayman Chemical |
| Supplier-Nr: | 37496 |
Properties
| Application: | Tertiapin peptide derivative, Kir channel inhibitor |
| Conjugate: | No |
| MW: | 2428 D |
| Formula: | C106H179N33O24S4 . XCF3COOH |
| Purity: | >98% |
| Format: | Solid |
Database Information
| KEGG ID : | K04999 | Matching products |
Handling & Safety
| Storage: | -20°C |
| Shipping: | +20°C (International: -20°C) |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow.
more
You will get a certificate here
Viewed